Arecor Therapeutics plc (AREC) ORD GBP0.01

- Add to watchlist
- Create an alert
- This stock can be held in a




86.50p
88.00p
97.50p
£32.66 million
86.50p
85.00p
35.40p
n/a
14.00p (19.31%) Previous:
14.00p
22,836
n/a
1,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/12/2024 | 31/12/2023 |
---|---|---|
Revenue (£m) | 5.05 | 4.57 |
Profit before tax (£m) | (10.62) | (8.90) |
Adjusted EPS (p): | (0.31) | (0.28) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Arecor enters formulation partnership with Skye Bioscience
19 May 2025 11:59
-
Arecor enters collaboration with unnamed global pharma major
26 March 2025 14:51
-
Revenue higher, cash reserves fall at Arecor
3 February 2025 14:40
-
Interim results for the six months to 30 June 2025
25 September 2025 07:00
-
Co-Development Agreement & Monetisation Deal
25 September 2025 07:00
-
Notice of Interim Results
24 September 2025 09:30
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.